FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/02/2025
Voltar para busca
Dado oficial do USPTO
N NUAGE THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 40, 42
Data de depósito
25/11/2022
Data de registro
30/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/07/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
ES
Examinador
BHANOT, KAPIL KUMAR
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording NUAGE THERAPEUTICS in a stylized font with the letter "N" within a circular border to the left.
Titulares e representantes
Titulares
Nuage Therapeutics, S.L.
Representantes
Lawrence Apolzon Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in product development in the fields of sciencescientific research and for laboratory use; in vitro analytical and diagnostic reagents for scientific use
Classe 5
Pharmaceutical preparations for targeting of disordered proteins; chemicalanalytical and diagnostic reagents for in vitro medical or veterinary use; chemical reagents for medical use; chemical reagents for use in medical or veterinary diagnostics; pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions and for the treatment of inflammation and inflammatory conditions and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the prevention and treatment of immune-relatedneurological and neurodegenerative diseases
Classe 40
Custom manufacture of cell lines for use in the manufacture of biopharmaceutical products; custom manufacture of proteins for third parties; custom manufacture of medicines; custom manufacture of biopharmaceuticals
Classe 42
Scientificmedicalmedical industrial research and development services; medical clinical research studies; laboratory medical research; research and development of new drugs and medical clinical products; analysis of materials; chemical analysis; medical and scientific laboratory services; laboratory medical testing services; medical laboratory services; information and advisory services relating to the aforesaidincluding such services provided online from a computer network or via the internet; research and development services for pharmaceutical preparations and for the treatment of diseases and injuries; genetic engineering services; genetic research for scientific or medical purposes; scientific research and development; scientific research in the field of genetics; medical and pharmacological research services; research and development in the fields of biotechnologybiopharmaceuticalsgene therapies; medical and scientific researchnamely conducting clinical trials; research and development of pharmaceutical products; research and development of vaccines and medicines; stem cell research; research and development in the fields of microorganisms and cells; research in the field of gene therapies; advisory services relating to gene therapy research; biological researchclinical medical research and medical research; product development; biological product development services; consultancy relating to pharmaceutical research and development; providing scientific information in the field of medical disorders and their treatment; pharmaceutical research and development; scientific services relating to the isolation and cultivation of human tissues and cells; research related to molecular science; analysis in the field of molecular biology; research services relating to molecular sciences
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/01/2025
FIMP
FINAL DISPOSITION PROCESSED
27/01/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
30/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/05/2024
PUBO
PUBLISHED FOR OPPOSITION
14/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/03/2024
RFNT
REFUSAL PROCESSED BY IB
17/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/09/2023
RFRR
REFUSAL PROCESSED BY MPU
27/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2023
CNRT
NON-FINAL ACTION WRITTEN
08/09/2023
DOCK
ASSIGNED TO EXAMINER
06/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
26/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/05/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace N NUAGE THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.